Does ANTI-INHIBITOR COAGULANT COMPLEX Cause Hypersensitivity? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hypersensitivity have been filed in association with ANTI-INHIBITOR COAGULANT COMPLEX (FEIBA). This represents 0.7% of all adverse event reports for ANTI-INHIBITOR COAGULANT COMPLEX.
10
Reports of Hypersensitivity with ANTI-INHIBITOR COAGULANT COMPLEX
0.7%
of all ANTI-INHIBITOR COAGULANT COMPLEX reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hypersensitivity From ANTI-INHIBITOR COAGULANT COMPLEX?
Of the 10 reports, 5 (50.0%) required hospitalization.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for ANTI-INHIBITOR COAGULANT COMPLEX.
What Other Side Effects Does ANTI-INHIBITOR COAGULANT COMPLEX Cause?
Haemorrhage (380)
Treatment failure (135)
Drug ineffective (129)
Therapy partial responder (104)
Haemarthrosis (92)
Acquired haemophilia (77)
Pre-existing disease (74)
Death (59)
Factor viii inhibition (56)
Anti factor viii antibody positive (49)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which ANTI-INHIBITOR COAGULANT COMPLEX Alternatives Have Lower Hypersensitivity Risk?
ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR HUMAN
ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT
ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED
ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT
ANTI-INHIBITOR COAGULANT COMPLEX vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT